Tekla Healthcare Investors
NYSE:HQH
18.48 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 58.118 | -192.265 | 157.103 | 242.922 | -143.631 | 70.971 | 123.06 | 55.06 | 4.332 | 2.144 | 1.956 |
| Cost of Revenue
| 10.895 | 11.296 | 12.169 | 10.423 | 10.016 | 10.39 | 10.235 | 10.675 | 0 | 0 | 0 |
| Gross Profit
| 47.223 | -203.561 | 144.933 | 232.5 | -153.648 | 60.581 | 112.825 | 44.386 | 4.332 | 2.144 | 1.956 |
| Gross Profit Ratio
| 0.813 | 1.059 | 0.923 | 0.957 | 1.07 | 0.854 | 0.917 | 0.806 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 0 | -0 | 0 | 0 | -0 | 0 | 0 | -0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 1.236 | 1.4 | 1.299 | 1.166 | 1.139 | 1.208 | 1.235 | 11.084 | 12.182 | 9.301 | 7.233 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1.236 | 1.4 | 1.299 | 1.166 | 1.139 | 1.208 | 1.235 | -0 | 12.182 | 9.301 | 7.233 |
| Other Expenses
| -33.211 | -257.585 | 78.335 | 159.631 | -221.252 | 42.216 | 40.649 | 39.004 | 0 | 0 | 0 |
| Operating Expenses
| 1.783 | 1.964 | 1.927 | 1.718 | 1.664 | 1.767 | 1.778 | 60.821 | 91.834 | 219.873 | 198.124 |
| Operating Income
| 56.335 | -194.229 | 155.176 | 241.205 | -145.295 | 69.204 | 121.283 | -6.283 | -7.851 | -7.157 | -5.276 |
| Operating Income Ratio
| 0.969 | 1.01 | 0.988 | 0.993 | 1.012 | 0.975 | 0.986 | -0.114 | -1.812 | -3.338 | -2.697 |
| Total Other Income Expenses Net
| -0.004 | -190.559 | -0.018 | -0.025 | -142.423 | 10.39 | 10.235 | -49.736 | 104.016 | 229.174 | 205.357 |
| Income Before Tax
| 56.335 | -194.229 | 155.176 | 241.205 | -145.295 | 69.204 | 121.283 | -56.019 | 96.165 | 222.017 | 200.081 |
| Income Before Tax Ratio
| 0.969 | 1.01 | 0.988 | 0.993 | 1.012 | 0.975 | 0.986 | -1.017 | 22.201 | 103.55 | 102.266 |
| Income Tax Expense
| -1.189 | -3.665 | -6.248 | -1.997 | -2.865 | -0.161 | -5.164 | 160.816 | 104.016 | 229.174 | 205.357 |
| Net Income
| 56.335 | -194.229 | 155.176 | 241.205 | -145.295 | 69.204 | 121.283 | -56.019 | 96.165 | 222.017 | 200.081 |
| Net Income Ratio
| 0.969 | 1.01 | 0.988 | 0.993 | 1.012 | 0.975 | 0.986 | -1.017 | 22.201 | 103.55 | 102.266 |
| EPS
| 1.14 | -4.1 | 3.49 | 5.5 | -3.39 | 1.53 | 2.99 | 1 | 2.58 | 6.2 | 7.22 |
| EPS Diluted
| 1.14 | -4.1 | 3.49 | 5.5 | -3.39 | 1.53 | 2.99 | 39,002,429 | 2.58 | 6.2 | 7.22 |
| EBITDA
| 57.524 | -190.565 | 161.424 | 243.202 | -142.43 | 69.204 | 121.283 | 0 | 104.016 | 229.174 | 205.357 |
| EBITDA Ratio
| 0.969 | 1.01 | 0.988 | 0.993 | 1.012 | 0.975 | 0.986 | 2.017 | 24.014 | 106.888 | 104.963 |